	US 11,987,607 B2
	Antimicrobial peptides with alpha-core helices
Nannette Y. Yount, San Juan Capistrano, CA (US); and Michael R. Yeaman, Redondo Beach, CA (US)
Assigned to The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA (US)
Filed by THE LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER, Torrance, CA (US)
Filed on Nov. 9, 2022, as Appl. No. 18/053,981.
Application 18/053,981 is a division of application No. 16/612,242, abandoned, previously published as PCT/US2018/032133, filed on May 10, 2018.
Claims priority of provisional application 62/505,013, filed on May 11, 2017.
Prior Publication US 2023/0227516 A1, Jul. 20, 2023
Int. Cl. C07K 14/37 (2006.01); C07K 14/435 (2006.01); C07K 14/46 (2006.01); C07K 14/465 (2006.01); C07K 14/47 (2006.01); G16B 15/20 (2019.01)

CPC C07K 14/4723 (2013.01) [C07K 14/43518 (2013.01); C07K 14/43522 (2013.01); C07K 14/43568 (2013.01); C07K 14/43572 (2013.01); C07K 14/43581 (2013.01); C07K 14/463 (2013.01); C07K 14/465 (2013.01); G16B 15/20 (2019.02)]

8 Claims

1. A method for treating an infection in a patient in need thereof, comprising administering to the patient a polypeptide comprising the amino acid sequence of SEQ ID NO: 3, wherein the peptide is not longer than 60 amino acid residues in length.